Dapagliflozin enhances gut barrier function in rats with chronic myocardial infarction by modulating gut microbiota balance
In this CMI rat model, dapagliflozin was associated with changes in the gut-heart axis that may relate to its observed cardioprotective effects. Further studies are required to determine causality and the relative contribution of these pathways.
Authors
- Chayodom Maneechote (ORCID: https://orcid.org/0000-0002-4379-8054)
- Chitlada Parbao
- Chanon Kunasol (ORCID: https://orcid.org/0000-0003-1744-0005)
- Wichwara Nawara
- Nipon Chattipakorn
- Chanisa Thonusin
- Nattayaporn Apaijai
- Siriporn C. Chattipakorn
Institutions
- The Royal College Of Anesthesiologists Of Thailand (TH)
- Office of the Royal Society
- Chiang Mai University (TH)
Publication Details
- Journal
- Annals of Translational Medicine
- Published
- 2025-12-01
- DOI
- https://doi.org/10.21037/atm-25-132
- Citations
- 1
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.81